Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Owen Adams Catherine. Insider active across 3 companies, notably AGIOS PHARMACEUTICALS, INC.. In total, 5 reports have been logged. History available since 13 June 2025. The latest transaction was disclosed on 24 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Owen Adams Catherine is a declarant and is listed as a director at Agios Pharmaceuticals, INC. and AGIOS PHARMACEUTICALS, INC., on XNAS. The record contains 4 filings in total, and across the sampled recent filings the period runs from 2025-06-17 to 2026-06-23, with reported buy and sell volumes of 0 EUR. The modal transaction nature is Levée d'options.